Houlihan Lokey 2022 Outlook
Hey all, current analyst at lower MM firm (think Stifel / Raymond James / Truist). I just got a first round interview for a non-RX (CF) role at Houlihan Lokey in NYC and am curious on overall outlook of the firm. I know they are a volume shop and closed the most deals last year but want to know more specifically on PE exits (details on which firms if possible), best non-RX groups, hours, culture, etc. Also, has anyone internally heard if they are raising base as it seems they used to be above street and now are slightly below?
Any insight would be greatly appreciated.
Current HL employee here. I love it - consumer, industrials, and healthcare are the groups you should target.
Any insight into recent PE exits and hours of those groups you mentioned? (Assuming NYC)
Dallas actually. Hours in my experience vary a lot - 60-85 hours most weeks. With 75 probably being the sweet spot. We are a volume shop across all industries so hours won’t vary a TON - expect to be constantly busy. Bright spot is we don’t pitch as much and have probably the best sponsor coverage out of the MMs, so you’re exposed to a ton of live deals and pretty much run the day to day. Recent analyst departures in my group have gone to VC and corp dev, but know my group has historically placed well to MM/MF shops. I love the culture in my group and really enjoy working here. Highly recommend
Do you think most of the positive things you mentioned (hours, placement, culture) holds true outside of your group/geography?
Sunt alias id porro culpa architecto. Eveniet dolore placeat tempora.
Hic dolor pariatur nostrum aspernatur. Ut quasi adipisci quo nam aliquid aut laudantium. Sit inventore sit voluptas porro quia eaque qui. Praesentium animi expedita aut aut. Modi quo non facilis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...